Lannett Company Overview

  • Founded
  • 1942
Founded
  • Status
  • Public
  • Employees
  • 954
Employees
  • Stock Symbol
  • LCI
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $4.56
  • (As of Friday Closing)

Lannett Company General Information

Description

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.

Contact Information

Website
www.lannett.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
  • 1150 Northbrook Drive
  • Suite 155
  • Trevose, PA 19053
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lannett Company Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.56 $4.85 $4.12 - $10.70 $189M 41.4M 524K -$4.97

Lannett Company Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 813,553 897,343 811,280 1,245,421
Revenue 510,689 545,744 655,407 684,563
EBITDA (165,404) 74,526 (206,027) 191,842
Net Income (195,290) (33,366) (272,107) 28,690
Total Assets 862,370 1,136,555 1,187,413 1,575,304
Total Debt 624,044 692,070 729,048 839,270
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lannett Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lannett Company‘s full profile, request access.

Request a free trial

Lannett Company Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical produ
Pharmaceuticals
Trevose, PA
954 As of 2020
000000000

000 0000

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
00000 0000000000 00000000
Baudette, MN
000 As of 0000
00000
000000000 00000

000000 0

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
000000000000000
Chicago, IL
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lannett Company Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ANI Pharmaceuticals Corporation Baudette, MN 000 00000 000000000 00000
000000 00000000000 Corporate Backed or Acquired Chicago, IL 000 00000 000000&0 00000
000 00000000 Private Equity-Backed Milan, Italy 00 000000000000
000 0000000 0000 0 Formerly PE-Backed Livonia, MI 000 000.00 000000&0 000.00
0000000 00000 Private Equity-Backed Morristown, NJ 000 00000 000000000 00000
You’re viewing 5 of 38 competitors. Get the full list »

Lannett Company Executive Team (10)

Name Title Board Seat Contact Info
Timothy Crew Chief Executive Officer & Board Member
John Kozlowski Chief Financial Officer and Vice President, Finance
John Abt Ph.D Chief Quality Operations Officer & Vice President
Robert Ehlinger Chief Information Officer & Vice President
Samuel Israel General Counsel, Legal & Chief Legal Officer, Legal
You’re viewing 5 of 10 executive team members. Get the full list »

Lannett Company Board Members (4)

Name Representing Role Since
0000000 0000000000 Lannett Company Board Member 000 0000
0000000 000000 Self Chairman & Board Member 000 0000
0000000 0000 Lannett Company Chief Executive Officer & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Lannett Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lannett Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lannett Company‘s full profile, request access.

Request a free trial

Lannett Company Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000000 07-May-2018 000000000 00000 00 Buildings and Property 0000000 0000
0000000 00000 0000 27-Nov-2015 000000000000000000 00.000 Pharmaceuticals 000000 000000000 00
000000 00000000000 01-Jun-2015 000000000000000000 000.00 Pharmaceuticals 000000 000000000 00
0000000 0000000 (0 20-Aug-2014 000000000000000000 Pharmaceuticals 000000 000000000 00
Cody Laboratories 10-Apr-2007 Merger/Acquisition Pharmaceuticals 000000 000000000 00
To view Lannett Company’s complete investments and acquisitions history, request access »

Lannett Company Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000000000 10-Apr-2007 000000000000000000 Completed
  • 0000000 0000000
To view Lannett Company’s complete exits history, request access »